Literature DB >> 22486415

The diagnostic accuracy of two methods for E6&7 mRNA detection in women with minor cytological abnormalities.

George Koliopoulos1, Charalambos Chrelias, Asimakis Pappas, Sofia Makridima, Emmanuel Kountouris, Maria Alepaki, Aris Spathis, Vicky Stathopoulou, Ioannis Panayiotides, Pericles Panagopoulos, Petros Karakitsos, Dimitrios Kassanos.   

Abstract

OBJECTIVE: To examine the diagnostic accuracy of nucleic acid sequence based amplification (NASBA) and flow cytometry for E6&7 human papillomavirus (HPV) mRNA detection in the triage of minor cytological abnormalities.
DESIGN: Prospective diagnostic accuracy study.
SETTING: Gynecology outpatient clinics of a university hospital. POPULATION: 472 women with low-grade squamous intraepithelial lesion (LSIL) or atypical squamous cells of undetermined significance (ASCUS).
METHODS: Residual material of the liquid-based smears was tested by NASBA and by flow cytometry for E6&E7 mRNA expression. Histological diagnosis was used as reference standard. MAIN OUTCOME MEASURES: Accuracy indices of the two techniques and of type 16-specific NASBA for the detection of cervical intraepithelial neoplasia (CIN) 2+ and CIN3+, accuracy indices at age >35 years, correlation between NASBA and flow, comparison between integrated and episomal high-risk HPV infection for risk of CIN2+.
RESULTS: Both tests showed increased positivity rates with increasing severity of the lesion (p < 0.05, chi-squared test for trend). There was a positive correlation between NASBA and flow results (phi coefficient = 0.325). NASBA-positive cases were more likely to have CIN2+ than were NASBA-negative/DNA-positive for types 16, 18, 31, 33, 45 (25/73 vs. 4/52, p= 0.0004; Fisher's exact test). In the LSIL group the NASBA accuracy indices for CIN3+ were: sensitivity 75%, specificity 78.7% and positivity rate 20.8%, and for flow 77.8%, 64.5% and 35.9%, respectively.
CONCLUSIONS: NASBA has favorable specificity and positivity rates for triaging LSIL prior to colposcopy. A relatively low sensitivity warrants cytological surveillance of the NASBA-negative LSILs. Flow cytometry does not perform as well overall.
© 2012 The Authors Acta Obstetricia et Gynecologica Scandinavica© 2012 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22486415     DOI: 10.1111/j.1600-0412.2012.01414.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  8 in total

1.  Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms.

Authors:  Rui-Lan Huang; Cheng-Chang Chang; Po-Hsuan Su; Yu-Chih Chen; Yu-Ping Liao; Hui-Chen Wang; Yi-Te Yo; Tai-Kuang Chao; Hsuan-Cheng Huang; Ching-Yu Lin; Tang-Yuan Chu; Hung-Cheng Lai
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

Review 2.  E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective.

Authors:  Massimo Origoni; Paolo Cristoforoni; Guia Carminati; Chiara Stefani; Silvano Costa; Maria Teresa Sandri; Luciano Mariani; Mario Preti
Journal:  Ecancermedicalscience       Date:  2015-04-29

3.  HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.

Authors:  Sveinung Wergeland Sørbye; Silje Fismen; Tore Jarl Gutteberg; Elin Synnøve Mortensen; Finn Egil Skjeldestad
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

4.  5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions.

Authors:  Bjørn Westre; Anita Giske; Hilde Guttormsen; Sveinung Wergeland Sørbye; Finn Egil Skjeldestad
Journal:  BMC Clin Pathol       Date:  2016-06-07

Review 5.  Accuracy of mRNA HPV Tests for Triage of Precursor Lesions and Cervical Cancer: A Systematic Review and Meta-Analysis.

Authors:  Ana Cristina L Macedo; João Carlos N Gonçalves; Daniela Vicente Bavaresco; Antonio José Grande; Napoleão Chiaramonte Silva; Maria Inês Rosa
Journal:  J Oncol       Date:  2019-06-11       Impact factor: 4.375

6.  Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study.

Authors:  Paolo Giorgi Rossi; Maria Benevolo; Amina Vocaturo; Donatella Caraceni; Lucia Ciccocioppo; Antonio Frega; Irene Terrenato; Roberta Zappacosta; Deborah French; Sandra Rosini
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

7.  An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection.

Authors:  Panagiotis Bountris; Maria Haritou; Abraham Pouliakis; Niki Margari; Maria Kyrgiou; Aris Spathis; Asimakis Pappas; Ioannis Panayiotides; Evangelos A Paraskevaidis; Petros Karakitsos; Dimitrios-Dionyssios Koutsouris
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

8.  γH2Ax Expression as a Potential Biomarker Differentiating between Low and High Grade Cervical Squamous Intraepithelial Lesions (SIL) and High Risk HPV Related SIL.

Authors:  Konstantinos Leventakos; Sotirios Tsiodras; Theodore Kelesidis; Maria Kefala; Christine Kottaridi; Aris Spathis; Alina-Roxani Gouloumi; Abraham Pouliakis; Asimakis Pappas; Vasileios Sioulas; Charalambos Chrelias; Petros Karakitsos; Ioannis Panayiotides
Journal:  PLoS One       Date:  2017-01-24       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.